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Selectivity indexA challenge when designing membrane-active peptide antibiotics with therapeutic potential is how to ensure a
useful antibacterial activity whilst avoiding unacceptable cytotoxicity for host cells. Understanding their mode of
interaction withmembranes and the reasons underlying their ability to distinguish between bacterial and eukary-
otic cytoplasmic cells is crucial for any rational attempt to improve this selectivity.We have approached this prob-
lem by analysing natural helical antimicrobial peptides of anuran origin, using a structure–activity database to
determine an antimicrobial selectivity index (SI) relating the minimal inhibitory concentration against Escherichia
coli to the haemolytic activity (SI=HC50/MIC). A parameter that correlated strongly with SI, derived from the
lengthwise asymmetry of the peptides' hydrophobicity (sequencemoment), was then used in the “Designer” algo-
rithm to propose novel, highly selective peptides. Amongst these are the ‘adepantins’, peptides rich in glycines and
lysines that are highly selective for Gram-negative bacteria, have an exceptionally low haemolytic activity, and are
less than 50% homologous to any other natural or synthetic antimicrobial peptide. In particular, they showed a very
high SI for E. coli (up to 400)whilst maintaining an antimicrobial activity in the 0.5–4 μM range. Experiments with
monomeric, dimeric and ﬂuorescently labelled versions of the adepantins, using different bacterial strains, host
cells and model membrane systems provided insight into their mechanism of action.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
New anti-infective agents with a reduced propensity for inducing
bacterial resistance are increasingly sought after to combat infections
by antibiotic resistant strains of bacteria [1]. Cationic antimicrobial
peptides (AMPs) produced by all higher organisms are ancient com-
ponents of innate immunity that have remained effective against bac-
teria throughout evolution [2,3]. For many of these peptides, the main
targets of action are the bacterial membranes and associated biologi-
cal functions [4]. Altering membrane features which favour interac-
tion with cationic AMPs, such as its composition rich in anionic
phospholipids or the strong, inside-directed electric ﬁeld, is a costly
process for bacteria and is limited in both extent and time [5]. Fur-
thermore, endogenously produced AMPs tend to act on multiple tar-
gets in bacteria, and can also have important pro-defensive effects on
host immune cells [6]. For all these reasons, AMPs have a relativelyoron-dipyrromethene; Gal-ONp,
for 50% haemolysis; IC50, concen-
r vesicles; MIC, minimum inhibi-
ion; PI, propidium iodide; TFE,
+385 21 384 086.
l rights reserved.low tendency to elicit resistance, and often display a signiﬁcant selec-
tivity for bacterial with respect to host cells.
Thousands of endogenous AMPs from a multitude of vertebrate
and invertebrate animals, plants and moulds have been reported
(for a comprehensive list of databases collecting their sequences see
[7]). A particularly abundant and wide-spread type of AMP acquires
an amphipathic α-helical secondary structure in a membrane-like en-
vironment [8]. Generally, however, the primary or secondary struc-
tures of these peptides have not been deﬁned by parameters that
can be quantitatively related to antibacterial and cytotoxic activities.
Even when such structural parameters are identiﬁed, altering them
so as to optimize the antibacterial activity whilst simultaneously
maintaining a low cytotoxicity, or reducing it, has been a considerable
challenge. An optimal combination of speciﬁc attributes favouring an
improved selectivity without losing activity is not easily achieved
[9–12]. Rational design methods for improving this balance would
beneﬁt from the identiﬁcation of inherent structural features of
AMPs which have evolved to ensure, within their natural context, a
selective action in fending off microbes without endangering host
cells.
A simple parameter used to quantify selectivity of AMPs (antimicro-
bial selectivity index or SI) is deﬁned as the ratio between the concen-
trations leading to 50% lysis of human erythrocytes and the minimum
concentration inhibiting bacterial growth (SI=HC50/MIC), which is
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SI values derived from published HC50 and MIC (Escherichia coli) data
for numerous anuran peptides in a dedicated database (AMPad) [13].
We used non-homologous sequences (less than 70% pair-wise identity
amongst themselves) as a training set to correlate numerous physico-
chemical properties to this quantitative activity data, so as to develop
an effective algorithm for predicting SI. The algorithm was successfully
veriﬁed against another set of anuran peptides of known activity from
AMPad, and was then implemented as a module of the ‘Designer’ tool,
with associated rational sequence restrictions, to design novel AMP se-
quences predicted to have a high SI [13,14].
The choice of estimating SI values, rather than attempting to di-
rectly predict antimicrobial activity of designed AMPs, has several ad-
vantages. Selectivity index values are more sensitive to small changes
in peptide sequence, so that one can more easily ﬁlter out descriptors
with low relevance. Secondly, when relevant descriptors and data
mining procedures are found, an enormous reduction in the number
of potential AMPs can be achieved, and a workable load of lead candi-
dates can be tested in dedicated experiments [14].
For example, amongst the 8×1029 possible sequences for a
23-residue peptide, the “Designer” tool selected only seven [13]. It
is based on two procedures, one to generate peptide sequences that
are potentially amphipathic helixes and have the characteristics of
potent anuran AMPs, and the second to identify those with the
highest predicted SI. Regarding the generation of peptide sequences,
the analysis of those in the AMPad database allowed extracting
mean and position-speciﬁc properties as well as motifs to guide the
insertion of residues at each position, adding them in such a way
that polar and non-polar amino acids remain separated correctly in
a helical wheel projection. It restricts sequences to a net positive
charge and mean hydrophobicity in a narrow range characteristic of
the best anuran peptides (potent AMPs with SI>20). An amino acid
selectivity index, derived from the same set of sequences, was applied
to ensure a threshold number of those residues whose relative fre-
quency is high in these peptides (E, D, Q, H, G). A motif regularity ﬁl-
ter was also applied, based on regularity matrices for pairs of residues
spaced i+1 and i+4 apart in the sequence [13]. Only at this stage
were the sequences subjected to SI prediction.
The second procedure is based on our observation that the length-
wise distribution of residue hydrophibicities along a peptide sequence
can affect its selectivity [15]. It results in a longitudinal component to
the peptide's amphipathicity, which we term the ‘sequence moment’Fig. 1. Sequence moments for adepantins 1 and 3 and the anuran peptide pseudin 2. For each
assigned to each position as represented by the small vector on this arc, having the same orig
based on a sliding window that takes into account the sequence environment about any give
grey were generated using the scales of Guy [16] and Janin [17], respectively. The sum of the
on the origin. The angle between these vectors, δ, correlates well with the selectivity indices
and HC50 values (human RBC), and its cosine, can thus be used to predict the SI of similar ar
give the best SI predictions for known anuran peptides, according to the linear, one-descrip[13,14]. This is to be distinguished from Eisenberg's ‘hydrophobic mo-
ment’ that considers the residue distribution around a helical wheel
projection, as it is dependent on the sequence rather than the secondary
structure. The sequence moment can be quantiﬁed by bending a se-
quence into a 90° arc and associating a hydrophobicity vector to each
position, with the same origin as the coordinate system (small vectors
in Fig. 1), and then calculating the vector sum (large vectors in Fig. 1).
We found that the angle between sequence moments generated using
two different scales correlated well with the peptide's selectivity, and
in particular between those calculated using the hydrophobicity scales
of Guy [16] and Janin [17]. The ﬁnal restriction on the generated se-
quences was thus that the predicted SI using these two scales has a
value higher than a set threshold.
A ﬁrst set of lead AMP candidates designed in this manner, with
E. coli as reference microorganism, were named adepantins (ADP1–7),
an abbreviation for Automatically Designed Peptide Antibiotic Number
1–7. ADP1 (GIGKHVGKALKGLKGLLKGLGES–NH2)was previously tested
and was found to be highly selective for Gram-negative bacteria, with
MIC values 2–4 μM against E. coli and 16 μM against Pseudomonas
aeruginosa, but over 128 μM against Staphylococcus aureus [13]. It
showed a remarkably low haemolytic activity (HC50>500 μM), indicat-
ing that the training process used in our algorithm had successfully
extracted the required selectivity attributes. This however needed to
be conﬁrmed for other lead adepantins, and also related to the mode
of action. To this end, in this paperwe describe the functional and struc-
tural characterisation of two other adepantins, and discuss these in re-
lation to the conﬁrmed high selectivity.2. Materials and methods
2.1. Peptide selection
The Designer algorithm is described in detail in reference [13]. It
proposed many 13 to 28 residue peptides predicted to have high SI
values based on the analysis of sequence moments, but by applying
restrictions to the primary sequences, structures and physicochemical
properties, these were narrowed down to seven candidates. The De-
signer tool, as well as the AMPad database, can be downloaded from
http://sites.google.com/site/adepantin1. SI values can be calculated
for any query sequence using the tool at http://split4.pmfst.hr/split/
dserv1/.peptide, the sequence is presented on an arc, and a smoothed hydrophobicity index is
in as the coordinate system. The smoothing procedure used to generate each index was
n position, and which contracts near the peptide termini. Vectors in light grey and dark
small vectors then results in the sequence moments shown as the large vectors centred
of peptides in a database of natural anuran AMP sequences with published MIC (E. coli)
tiﬁcially generated sequences. The scales of Guy and of Janin were previously found to
tor ﬁt SI=50.1−44.8×cos(δ) [13,14].
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spectively chosen as having the most and least similar primary sequence
compared toADP1 (Table 1). BothADP2 and 3 carry a C-terminal cysteine
by which they are amenable to covalent dimerisation or ﬂuorescent
labelling.2.2. Peptide synthesis and characterisation
Peptides were synthesized as C-terminal amides on CEM Liberty au-
tomated microwave peptide synthesizer (CEM Corporation, Matthews,
NC) using Fmoc-PAL-PEG-PS resin (substitution 0.34 mmol/g). Cou-
plings were carried out with a fourfold excess of amino acids and
PyBop as activator, at 75 °C in DMF. Preactivated Fmoc-Cys(-Trt)OPfp
was used at 45 °C to reduce racemisation during the ﬁrst C-terminal
coupling. Fmoc deprotection was with 20% piperidine in DMF, whilst
cleavage of peptide from the resin was performed with a triﬂuoroacetic
acid (TFA), thioanisol, phenol, water, 3,6-dioxa-1,8-octanedithiol,
triisopropylsilane mixture (83:3:2:2:8:2, v/v/v/v/v/v) for 3 h at
room temperature. After cleavage, the peptides were precipitated
in and repeatedly extracted with t-butyl methyl ether. Puriﬁcation
was carried out on a preparative reversed phase Waters RadialPak
C18 column (21 mm×150 mm, 5 μm, 300 Å), using a 20–55% gradi-
ent of acetonitrile in 70 min. Peptide purity was conﬁrmed by
ESI-MS on an Esquire 4000mass spectrometer (Bruker Daltonics, Bil-
lerica, MA).
After lyophilisation, aliquots of adepantins 2 and 3 were either
acetamidated on the Cys residues, dimerised, or labelled with a
ﬂuorescent probe. Intermolecular disulﬁde bridge formation was
achieved by suspending peptides in a water/DMSO (80:20) mixture at
6.5 pH for 48 h [18]. Peptide acetamidation and labelling with BODIPY-
N-(2-aminoethyl)maleimide (BY) were performed as described [19,20].
After each procedure, the peptides were subjected to RP-HPLC and
ESI-MS to verify the correctmass and purity and then theywere repeat-
edly lyophilized from 10 mM HCl to remove TFA, before storage in the
dark at−20 °C. Peptide concentrations of stock solutions were deter-
mined spectrophotometrically using the method of Waddell [21] as
well as the calculated molar extinction coefﬁcient at 214 nm [22]. For
bodipylated peptides, the extinction coefﬁcient of BODIPY was used
[79,000 M−1 cm−1 at 504 nm in MeOH, Molecular Probes Handbook,
Invitrogen, 10th Ed. p. 107].2.3. Circular dichroism
CD spectroscopy was performed on a J-715 spectropolarimeter
(Jasco, Tokyo, Japan) using 2 mm path length quartz cells and pep-
tides (20 μM with respect to the peptide chains) in PBS 150 mM
NaCl, 50% isopropanol (iPrOH) in SPB, 50% TFE in SPB and anionic or
neutral liposomes (see below), to determine the peptides' propensity
to interact with a membrane-like environment and to assume helical
conformations. The helical content (% helicity) was estimated fromTable 1
Sequences and physicochemical properties of designed adepantin peptides and natural anu
Peptide Amino acid sequencea Hb
ADP1 GIGKHVGKALKGLKGLLKGLGES–NH2 −1.0
ADP2 GIGKHVGKALKGLKGLLKGLGEC–NH2 −0.9
ADP3 GLKGLLGKALKGIGKHIGKAQGC–NH2 −1.1
Pseudin 2 GLNALKKVFQGIHEAIKLINNHVQ–NH2 −0.5
Ascaphin 1 GFRDVLKGAAKAFVKTVAGHIAN–NH2 −1.1
a Residues that vary in ADP2 and 3 with respect to ADP1 are underlined.
b H=mean per residue hydrophobicity, μHrel=mean relative hydrophobic momen
www.bbcm.univ.trieste.it/~tossi/HydroCalc/HydroMCalc.html), not considering the ami
18-residue helical peptide.
c δ=sequencemoment angle (see Fig. 1), SIpred=predicted selectivity index, based on the D-the molar ellipticity at 222 nm [23]. All displayed CD spectra are the
accumulation of at least three scans.
2.4. Preparation of liposomes
Two types of LUVs (large unilamellar vesicles) were prepared
as described in [24]. Brieﬂy, dry anionic phosphatidylglycerol/
diphosphatidylglycerol lipids (PG/dPG, 95:5 w/w) or neutral
phosphatidylcholine/sphingomyelin/cholesterol lipids (PC/SM/Ch,
40:40:20 w/w) were dissolved in Chloroform/Methanol (2:1) solution,
then evaporated using a dry nitrogen stream and vacuum-dried for 3 h.
All lipids were from Sigma. The liposomes were resuspended in 1 ml of
PBS to a concentration of 4 mMphospholipid and spun for 1 h at 40 °C.
The vesicles were subjected to several freeze–thaw cycles before pass-
ing through amini-extruder (Avanti Polar Lipids, Alabaster, AL) through
successive polycarbonate ﬁlters with 1 μm, 0.4 μm and 0.1 μm pores.
Final liposome concentrations were 0.4 mM phospholipid.
2.5. Bacterial cells and growth conditions
The antibacterial activity of the peptides was tested against the ref-
erence strains E. coli ATCC 25922, S. aureus ATCC 25923, P. aeruginosa
ATCC 27853, Salmonella typhimurium ATCC 14028 and a clinical isolate
of Klebsiella pneumoniae. E. coli ML-35 pYC strain was used for the
outer- and inner-membrane permeabilisation assay [25]. To test for
the barrier effect of the outer membrane, the E. coli BW 25113 (a K12
strain) was used with its deletion mutant ΔwaaP [26]. All the bacterial
strainswere stored at−80 °C and routinely grownontoMuellerHinton
(MH) agar plates (Oxoid, Cambridge, UK).
2.6. Antimicrobial activity assays
Minimum inhibitory concentration (MIC) values of the peptides
were determined using a broth microdilution susceptibility test as pre-
viously described [27]. Brieﬂy, serial two-fold dilutions of each peptide
were prepared (ﬁnal volume of 50 μl) in 96-well polypropylene micro-
titer plates (Sarstedt, Nümbrecht, Germany) with MH broth. Each dilu-
tion series included control wells without peptide. A total of 50 μl of the
adjusted inoculum (approximately 5×105cells/ml in MH broth) was
added to each well. The MIC was taken as the lowest concentration of
antimicrobial peptide resulting in the complete inhibition of visible
growth after 18 h of incubation at 37 °C. Results are mean values of at
least three independent determinations.
To determine the effects of peptides on bacterial growth kinetics,
200 μl suspensions of a mid-logarithmic bacterial culture (~1×
106cells/ml in MH broth) were placed in 96-well plates and incubated
in a microplate reader (Tecan, Männedorf, Switzerland) at 37 °C, with
periodic shaking, in the presence of different peptide concentrations
[28]. The optical density (OD) at 620 nm was measured every 10 min
for 4 h. IC50 value was taken as the mean concentration of the peptide
which inhibits bacterial growth by 50% at 210 min.ran AMPs used for comparison.
μHrelb δc Dc SIpredc
0.66 143° −0.80 86
0.66 156° −0.91 91
0.51 176° −1.00 95
0.58 15° 0.97 7
0.43 95° −0.08 54
t (relative amphipathicity), as calculated using the HydroMCalc applet (http://
dated C-termini. The hydrophobic moment is relative to a perfectly amphipathic,
descriptor value (cosδ), as estimated using the applet at http://split4.pmfst.hr/split/dserv1/.
Table 2
Structural characteristics of tested adepantin peptides.
Peptidea Chargeb MWcalcc MWmeasc % helical conformationd
H2O TFE LUVPG LUVPC
ADP1 5 2259.0 2259.7 b5 35 55 b10
ADP2 5 2275.8 2275.4 – – – –
ADP2(BY) 5 2689.8 2689.6 (b5)e (40) (50) (b10)
ADP2(AM) 5 2332.9 2332.4 b5 45 60 b5
[ADP2]2 10 4549.6 4549.3 b5 40 50 b10
ADP3 6 2246.8 2246.5 – – – –
ADP3(BY) 6 2660.8 2660.5 (b5)e (55) (50) (b5)
ADP3(AM) 6 2303.8 2303.3 b5 30 53 b10
[ADP3]2 12 4491.5 4491.5 b5 40 45 b10
a ADP2 and 3 were not used as such, but either acetamidated at the C-terminal cys-
teine residue (AM), labelled with BODIPY maleimide at this residue (BY), or dimerised
[ADP]2.
b Includes the N-terminus and considers histidine to be neutral.
c Calculated using the Peptide Companion software, measured with ESI-MS.
d Percent helicity determined according to Reed and Reed [23], using 20 μM helix in
aqueous solution, 50% triﬂuoroethanol (TFE), anionic LUVPG (phosphatidylglycerol/
diphosphatidylglycerol; 95:5) and neutral LUVPC (phosphatidylcholine/sphingomyelin/
cholesterol; 2:2:1) in SPB buffer. Ellipticitywas normalised per residue to take dimerisation
into account.
e Not corrected for the presence of the BODIPY chromophore.
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following MIC assay. At the end of MIC assay 10 μl aliquots of the me-
dium were taken from peptide-containing wells with no visible bac-
terial growth. These were plated on MH agar, incubated for 24 h to
allow colony growth. Peptide concentration causing at least a 99.9%
reduction of the number of bacteria present at the beginning of MIC
assay was deﬁned as MBC value [29].Fig. 2. Structure of adepantins in different environments. CD spectra of peptides (20 μM of
(iPrOH), 50% triﬂuoroethanol (TFE), 1:1 phosphatidylglycerol/diphosphatidylglycerol LUV
PBS (PC/SM/Ch). The bottom right panel shows % helix with increasing TFE {ADP1(——
[ADP3]2 (−⋅⋅−⋅⋅−, —△—)}.2.7. Bacterial membrane permeabilisation assays
The permeabilisation of the outer membrane of E. coli by the pep-
tides was evaluated by following the unmasking of the periplasmic hy-
drolytic enzyme β-lactamase, using extracellular CENTA® as substrate
[30], whilst that of the cytoplasmic membrane by unmasking cytoplas-
mic β-galactosidase activity using extracellular o-nitrophenyl-β-D-
galactopyranoside (Gal-ONp) as substrate, as described previously
[25,15]. The hydrolysis of both chromogenic substrates was moni-
tored at 405 nm on a microplate reader. The β-galactosidase con-
stitutive, lactose-permease deﬁcient E. coli ML-35 pYC strain was
used (~107cells/ml bacteria), in the presence of 0.5 μM peptide
and 0.15 mM CENTA or 0.25 μM peptide and 1.5 mM Gal-ONp in
PBS.
Cytoplasmic membrane permeabilisation was also determined by
ﬂow cytometry, measuring propidium iodide (PI) uptake by bacterial
cells [31]. A mid-logarithmic culture of E. coli ATCC 25922, diluted to
1×106cells/ml, was incubated in MH broth with 0.25 μM peptides at
37 °C for different times. PI (Sigma-Aldrich, St Louis, MO) was then
added to the peptide-treated bacteria at a ﬁnal concentration of
10 μg/ml, and the cells were analysed in a FC500 ﬂow cytometer
(Beckman Coulter, Lexington, MA) after the given incubation times.
Data analysis was performed with the FCS Express3 software (De Novo
Software, Los Angeles, CA) and results are expressed as percentage of
PI-positive cells.
2.8. Cytotoxic activity
The haemolytic activity of the peptides was determined by moni-
toring the release of haemoglobin at 405 nm using freshly isolated
human red blood cells from healthy donors. Aliquots of 0.5%peptide chain) measured in phosphate buffered saline (PBS, pH7.4), 50% isopropanol
s in PBS (PG/dPG) or 2:2:1 phosphatidylcholine/sphingomyelin/cholesterol LUVs in
, —●—), ADP2 (− − −, —■—), ADP3 (- - -, —▲—), [ADP2]2 (−⋅−⋅−, —□—) or
Table 3
Antimicrobial and cytotoxic activities of adepantin peptides.
Peptide MIC (μM)a MBC (μM)b IC50 (μM)c HC50(μM)d SIe
E. coli
ATCC 25922
S. aureus
ATCC 25923
P. aeruginosa
ATCC 27853
S. typhimurium
ATCC 14028
K. pneumoniae
(ci)
E. coli
ATCC 25922
E. coli
ATCC 25922
RBC
ADP1 2–4 >128 16 – – 4 1.5±0.3 480±60 190±90
ADP2(AM) 1 >128 32 16–32 64 2 0.8±0.1 400±100 400±100
[ADP2]2 0.5–1 128 2 1 1 2 0.2±0.05 16±4 16±4
ADP3(AM) 4 >128 – – – 8 2.3±0.3 >500 >125
[ADP3]2 0.5 64–128 – – – 0.5–1 0.2±0.05 20±4 40±8
a Carried out in 100% (v/v) MH broth using 5×105cells/ml bacteria in the logarithmic phase—mean of at least 3 independent determinations carried out in duplicate.
b Concentration resulting in no bacterial growth, 2 independent determinations carried out in duplicate.
c Concentration resulting in 50% inhibition of growth, as calculated from data shown in Fig. 3B.
d Concentration resulting in 50% haemolysis of red blood cells (0.5% v/v) determined from data shown in Fig. 4.
e Selectivity index calculated as HC50/MIC for E. coli.
1008 N. Ilić et al. / Biochimica et Biophysica Acta 1828 (2013) 1004–1012erythrocyte suspension in PBS done three times in triplicate, were in-
cubated with different peptide concentrations, varying from 5 μM to
500 μM, at 37 °C for 30 min. 100% haemolysis was determined byFig. 3. Effect of peptides on bacterial growth kinetics. A) E. coli growth kinetics curves in the abse
1 μM for ADP1, ADP2(AM), ADP3(AM) and 0.5 μM for dimers; B) % inhibition determined from
[ADP2]2 (−⋅−⋅−,—□—) or [ADP3]2 (−⋅⋅−⋅⋅−,—△—); C) Effect of ADP2 and D) effect of
and S. typhimurium (4). These curves allowed the determination of the IC50 values shown in T
triplicate.addition of Triton X-100 (0.2% ﬁnal concentration). HC50 value was
taken as the mean concentration of the peptide causing 50%
haemolysis.nce of peptides (⋅⋅⋅⋅⋅⋅⋅⋅) and in the presence of adepantinswith peptide concentrations of
the growth curves at 210 min ADP1(——,—●—), ADP2 (−−−,—■—), ADP3 (- - -,—▲—),
[ADP2]2 on the growth kinetics of E. coli (1), P. aeruginosa (2), K. pneumoniae (3)
able 3. The error barswere determined from the results of three experiments carried out in
Fig. 4. Haemolytic activity of peptides. Erythrocytes 0.5% (v/v) were treatedwith increas-
ing peptide concentrations (ADP1 —●—; ADP2 —■—; ADP3 —▲—; [ADP2]2 —□—;
[ADP3]2 —△—). Error bars were determined from four experiments carried out in
triplicate.
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BODIPY-labelled peptides (0.1 and 1 μM) and treated with PI for
5 min at room temperature. Membrane interaction and membrane
permeabilisation were determined by ﬂow cytometry by respectively
monitoring ﬂuorescence at 525 nm (BODIPY) and 610 nm (PI) at 5,
15 and 30 min, after which the treated cells were incubated with
0.1% trypan blue (TB) quencher, to distinguish between surface
bound peptide (quenched) and internalised peptide (unquenched).
3. Results and discussion
3.1. Peptide design and structural characterisation
A series of peptide sequences predicted to have high selectivity
index values for activity with respect to Gram-negative bacteria was
generated using theDesigner algorithm [13,14]. One of these, adepantin
1 (ADP1), was functionally characterised and conﬁrmed to have a high
selectivity for Gram-negative bacteria with respect to blood cells. Two
more peptides from the series, ADP2 and ADP3 (Table 1)were prepared
to further conﬁrm the efﬁcacy of the Designer tool. Structurally, ADP2 is
very similar to ADP1, but contains a C-terminal cysteine instead of ser-
ine, whilst ADP3 is only 35% identical, also bearing a C-terminal cyste-
ine. This residue allows anchoring of a ﬂuorescent probe, useful for
studying membrane interactions and internalisation into cells. It also
permits formation of covalent dimers, so as to probe the effects of ag-
gregation. In the monomeric form, it was iodoacetamidated to prevent
artefacts due to the reactivity of the sulfhydryl group.
The Designer algorithm used the lengthwise asymmetry of residue
hydrophobicities to predict the SI, as brieﬂy described in the intro-
duction [13,14]. The smoothed hydrophobicity proﬁles and sequence
moments for ADP-1 and -3 are shown in Fig. 1. The conversion of a
peptide's smoothed hydrophobicity proﬁle into a single sequence
moment vector is a drastic reduction of the information contained
by the proﬁle, but appears to preserve the lengthwise asymmetry in-
formation relevant to the peptide's biological activity. This observa-
tion led to the choice of the best pair of hydrophobicity scales to use
in this context (those of Guy [16] and of Janin [17]) and to the cosine
of the angle between corresponding sequence moments as being the
simplest quantitative structure–activity parameter having a good cor-
relation with the SI.
Fig. 1 illustrates this concept by comparing ADP1, ADP3 with
pseudin-2. The latter peptide, with δ=15°, has a low predicted selec-
tivity (SIpred=7, Table 1), and in fact has a very mediocre measured
SI=6 [13]. ADP1 and ADP3, with δ=143° (SIpred=86) and δ=176°
(SIpred=95) respectively, were predicted to be much more selective,
and this had been experimentally veriﬁed for ADP-1 (SI=200 [13]).
Note that the linear, one-descriptor ﬁt is limited between allowable
SIpred values of 5.3 and 94.9, so that the closer the predicted value is
to the higher limit, as is the case for ADP-2 and -3 (Table 1), the
higher the experimental SI value is likely to be, and it could in fact
be well above this value.
The peptides were synthesized in good yields (≥90%) and split into
aliquots for different types of handling. To test the activity of monomer-
ic peptides, the reactive sulfhydryl groups of the C-terminal cysteine
residue were iodoacetamidated to avoid reactionwithmedium compo-
nents. The resultingmodiﬁed side chainmay have hydrophobicity char-
acteristics similar to those of glutamine. BODIPY (BY) was chosen to
ﬂuorescently label the peptide at the C-terminal cysteine, as it is stable,
strongly ﬂuorescent and unlike FITC, uncharged. It enabled us to follow
the peptides' interaction with microbial and host cells. Covalent
dimerisation required formation of an intermolecular disulphide bridge.
Since AMPs often function by aggregating at the membrane surface,
which affects both antimicrobial activity and cytotoxicity to host cell
membranes, it allowed us to probe this effect. The correct structure
and quality of all peptides were conﬁrmed using analytical RP-HPLC
coupled with ESI-MS (Table 2).CD spectroscopy was used to study conformational properties of
adepantins in different environments. In water or aqueous buffers
all peptides were substantially random coil (Table 2). In the presence
of organic solvents such as 50% triﬂuoroethanol (TFE) or isopropanol
(iPrOH) they undergo a transition to a helical conformation with dif-
ferent propensities (Fig. 2, Table 2). Determination of the percent
helicity in a 5%–50% TFE range indicated that the transition was effec-
tively complete at ≥30% TFE (Fig. 2). Covalent dimerisation did not
markedly affect either the intensity or shape of the spectra with re-
spect to the monomers, so that helix stacking did not appear to be rel-
evant in the presence of helix-favouring solvent. Conversely, the
shape, and in particular the θ208/θ222 ratio of the spectra in the pres-
ence of anionic LUVs, suggested that the peptides may interact with
these membranes in an aggregated helical form, and this was partic-
ularly evident with the covalently linked dimers. Both monomeric
and dimeric peptides instead remained substantially as random
coils in the presence of neutral LUVs, suggesting that they did not ef-
ﬁciently insert into this type of membrane.
3.2. Antimicrobial activity
The antimicrobial activity of the peptides was assessed by deter-
mining both the minimum inhibitory concentration (MIC) and half
maximal growth inhibitory concentration (IC50), against selected
Gram-negative and Gram-positive bacteria (Table 3). In the MIC
assay, the dimeric peptides were found to be more active against
Gram-negative bacteria than the acetamidated monomeric versions.
IC50 values obtained from bacterial growth inhibition assays (Fig. 3)
conﬁrmed these trends. It was signiﬁcant that a single residue modi-
ﬁcation at the C-terminus (Ser in ADP1 to acetamidated Cys in
ADP2(AM)) considerably affected activity. Furthermore, all peptides
showed a lower potency against the Gram-positive S. aureus. This
conﬁrms that the activity of adepantins in general is directed against
Gram-negative bacteria. ADP2(AM) and its dimer were tested also
against other Gram-negative microorganisms (Fig. 3C and D), and
the monomer was somewhat less effective against K. pneumoniae,
S. typhimurium or P. aeruginosa than against E. coli, the bacterial tar-
get used in the computational approach underlying the Designer al-
gorithm, whilst the dimer showed a more potent, broad-spectrum
activity. Determination of the minimal bactericidal concentration indi-
cated that these peptides consistently have two-fold higher MBC than
the MIC values (Table 3). Considering also the bacterial growth
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at a threshold concentration of between 1 and 8 μM, depending on the
peptide, whilst they are bacteriostatic at subtoxic concentrations.3.3. Cytotoxic activity towards host cells
All three monomeric adepantins were found to have very low
haemolytic activities, assessed using 0.5% fresh human red blood
cells (RBC) (Fig. 4) with comparably high HC50 values (>400 μM),
resulting in SI values >125 (Table 3). The HC50 values were over an
order of magnitude lower for dimeric ADP2 and 3, which displayed
a signiﬁcant toxicity at antimicrobial concentrations. CD spectra in
the presence of neutral LUVs, mimicking host-cell membranes, do
not indicate a high degree of helical structuring (Fig. 2), indicating
that the peptides do not insert into this type of membrane. It may
be that the dimeric peptides are capable of lysing host cells via a
surface-type interaction. The different cytotoxicity of monomericFig. 5. Interaction of ADP2 and ADP3 with U937 cells. Monoparametric histograms for U93
ADP3-BY (B), and with the impermeant, extracellular quencher Trypan blue also added (d
ADP3-BY (D). Human leukemic monocytes (U937, 106cells/ml) were incubated with BO
with Trypan blue or PI for 5 min, and then monitoring ﬂuorescence at 525 nm (BODIPY) anand dimeric peptides suggests that peptide aggregation may be im-
portant in favouring this process.
To further probe the interaction of adepantins with host cells, a
ﬂow cytometric study was carried out on U937 cells in the presence
of ﬂuorescently labelled ADP2-BY and ADP3-BY. By treating the cells
with the impermeant quencher Trypan blue, it was possible to deter-
mine if peptide ﬂuorescence was on the surface of the cells, or if some
were internalised into the cytoplasm. By treating with PI, it was pos-
sible to probe whether the peptides induced membrane lysis at the
concentrations used. In Fig. 5A–D, it can be seen that treatment
with either of the ﬂuorescently labelled adepantins shifts the
monoparametric peak to a considerably higher position, indicating
that the peptides bind efﬁciently to the cell surface. They do so rapidly
(within 5 min) and in a dose dependent manner up to 1 μM (results
not shown). Treating with the quencher efﬁciently reduces ﬂuores-
cence, indicating that the peptides remain bound to the outside sur-
face of the cells. Co-treatment of cells with PI showed that this
occurs without subsequent membrane damage, as the signal shifts7 cells in the absence (empty curves) and presence (ﬁlled curves) of ADP2-BY (A) and
ashed line). Fluorescence dot plots for monocytes treated with PI and ADP2-BY (C) or
DIPY-labelled peptides (1 μM) for 30 min at room temperature before treating cells
d 610 nm (PI) on the ﬂow cytometer.
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the 610 nm ﬂuorescence axis (PI). These results conﬁrm that the pep-
tides interact with the surface of host cells, but are not cytotoxic at
antimicrobial concentrations, in the monomeric form.
3.4. Interaction with bacterial membranes and permeabilisation
CD studies suggested an efﬁcient insertion of adepantins into anion-
ic membranes (Fig. 2), which could initiate a process leading to mem-
brane permeabilisation as part of their mode-of-action. Adepantins
are selective for Gram-negative bacteria, but they must ﬁrst overcome
the outer membrane barrier to reach and lyse the cytoplasmic mem-
brane. To study the permeabilisation of both types of membranes, we
used the E. coli ML-35 pYC strain, which constitutively produces both
a cytoplasmic β-galactosidase and periplasmic β-lactamase. Damage
to the outer membrane allows CENTA, a chromogenic substrate for
the lactamase, to enter the periplasmic region, with an increased ab-
sorption at 405 nm. Damage to the cytoplasmic membrane allows
Gal-ONp, a chromogenic substrate for the galactosidase, to reach this
enzyme, also increasing absorption at 405 nm. Fig. 6A and B shows
the hydrolysis curves for this strain when treated with the peptides in
the presence of extracellular chromogenic substrates. Treatment with
dimeric adepantins results in a signiﬁcantly faster hydrolysis of both
substrates than the monomeric adepantins, consistent with moreFig. 6. Permeabilisation of the inner and outer membrane of E. coliML-35 pYC by adepantins a
determined by following the hydrolysis of the impermeant chromogenic substrate Gal-ONp by
following the hydrolysis of the impermeant chromogenic substrate CENTA® by the periplasm
25113 strain; D) Effects of adepantins on the growth kinetics of the E. coliBW25113ΔwaaP straiefﬁcient membrane permeabilisation kinetics. Dimerisation seems to
favour passage through both the outermembrane and permeabilisation
of the cytoplasmic membrane, and this may be related to their greater
potency.
To further test the barrier effect of the outer membrane, the activity
of the peptideswas tested against the E. coli BW25113 strain (a K12 de-
rived strain in which the LPS lacks the O-antigen polysaccharide), and a
mutant of BW 25113 with an incompletely formed core saccharide so
that the outer membrane is signiﬁcantly destabilised. In E. coli, the
waa locus contains several genes coding for enzymes involved in mod-
iﬁcation and assembly of the heptose region of the LPS core oligosaccha-
ride, whose structure is critical for outer membrane stability. The
ΔwaaP mutant, in which the waaP gene is deleted, lacks a kinase re-
quired for phosphorylation of the inner heptose in the core oligosaccha-
ride, onwhich subsequent heptose additions andmodiﬁcations depend.
The LPS is destabilised and this results in hypersensitivity to antimicro-
bial agents, including peptides, a characteristic of deep-rough muta-
tions [26].
In bacterial growth inhibition assays, the E. coli BW25113 strain be-
haves similarly to the ATCC 25922 strain, with themonomers inhibiting
growth in the order ADP2>ADP1>ADP3, and the dimers being much
more effective than the monomers (Fig. 6C). The presence of the
O-antigen polysaccharide thus does not seem to contribute to a barrier
effect. The ΔwaaP deletion mutant shows a similar trend, with just and effect on bacterial growth kinetics. A) Permeabilisation of the cytoplasmic membrane
a cytoplasmic β-galactosidase; B) Permeabilisation of the outermembrane determined by
ic enzyme β-lactamase, C) Effects of adepantins on the growth kinetics of the E. coli BW
n; (no peptide—○—; ADP1—●—; ADP2—■—; ADP3—▲—; [ADP2]2—□—; [ADP3]2—△—).
Fig. 7. Permeabilisation of E. coli ATCC 25922 to PI. Permeabilisation of the cytoplasmic
membrane was determined by % of PI-positive bacterial cells by ﬂow cytometric analyses.
Bacteria at 106cells/ml were treated with 0.25 μM peptides before adding PI; (ADP1
—●—; ADP2 —■—; ADP3 —▲—; [ADP2]2 —□—; [ADP3]2 —△—). BODIPY-labelled ADP2
and ADP3 were also tested (ADP2-BY —⋄—; ADP3-BY —▽—).
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together, these results indicate that the LPS layer of the outer mem-
brane is not a signiﬁcant barrier for adepantins, in particular for the di-
meric form.
Permeabilisation of the cytoplasmic membrane was further studied
bymonitoring the internalisation of PI into the E. coliATCC 25922 strain.
At the concentrations used (0.25 μM), which are sub-toxic for the
monomers, no permeabilisation was evident (Fig. 7), whilst for the di-
mers it was over 90% within 15 min, in agreement with both their in-
creased antimicrobial activity and increased permeabilisation to
Gal-ONp (Fig. 6A). Fluorescent labelling ofmonomeric peptides also ap-
pears to increase the permeabilisation of E. coli cells although this shows
curious and as yet unexplained time dependence.
In conclusion, we have conﬁrmed that the Designer algorithm is ca-
pable of elaborating AMPs that are highly selective for Gram-negative
bacteria, and in particular E. coli, having very high selectivity indices.
The exceptionally low cytotoxicity towards eukaryotic cells and inactiv-
ity against Gram-positive bacteria, suggest them as potentially useful
tools for exploring selectivity mechanisms. A common characteristic
of these short, linear AMPs is the capacity to adopt a helical structure
in the presence of negatively chargedmembranes, which favours inser-
tion into and permeabilisation of these,whilst they only appear to inter-
actwith the surface of neutralmembranes. The fact that their sequences
are particularly rich in glycine residuesmight have some signiﬁcance in
this respect. Furthermore, it appears that the capacity to dimerise plays
a signiﬁcant role inmodulating both the antimicrobial activity and cyto-
toxicity towards host cells, as shown by covalently dimerised peptides.
These results, apart from conﬁrming the validity of our computational
AMP design method, and setting the foundations for the design of fur-
ther optimised variants that may be developed into useful anti-
infective agents, bring some new insights into the mode of action of
the numerous and important class of amphipathic, helical AMPs.
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